Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Spike glycoprotein (2019-nCoV) | BDBM50568789 (Hypocrellin A | Rel-Hypocrellin A) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid UniChem | Article PubMed | n/a | n/a | 38 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of spike glycoprotein S in SARS-CoV-2 pseudovirus infected in human 293T/ACE2 cells assessed as inhibition of viral infection pretreated t... | Citation and Details Article DOI: 10.1021/acs.jnatprod.0c01136 BindingDB Entry DOI: 10.7270/Q2PN99DW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM50422742 (CHEMBL5274408) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Similars | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM50568790 (CHEMBL4869623) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | Article PubMed | n/a | n/a | 120 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of spike glycoprotein S in SARS-CoV-2 pseudovirus infected in human 293T/ACE2 cells assessed as inhibition of viral infection pretreated t... | Citation and Details Article DOI: 10.1021/acs.jnatprod.0c01136 BindingDB Entry DOI: 10.7270/Q2PN99DW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM22985 (Aralen | CHEMBL76 | CHLOROQUINE PHOSPHATE | Chloro...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG PC cid PC sid PDB UniChem Patents Similars | Article PubMed | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of spike glycoprotein S in SARS-CoV-2 pseudovirus infected in human 293T/ACE2 cells assessed as inhibition of viral infection pretreated t... | Citation and Details Article DOI: 10.1021/acs.jnatprod.0c01136 BindingDB Entry DOI: 10.7270/Q2PN99DW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM50568791 (CHEMBL4861894) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 170 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of spike glycoprotein S in SARS-CoV-2 pseudovirus infected in human 293T/ACE2 cells assessed as inhibition of viral infection pretreated t... | Citation and Details Article DOI: 10.1021/acs.jnatprod.0c01136 BindingDB Entry DOI: 10.7270/Q2PN99DW | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571393 (4-chloro-N-(4-(((3aR,6aS)-tetrahydro-1H-furo[3,4-c...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description After infection, supernatants were removed, and cells were fixed with 4% formaldehyde for 24 hours prior to being removed from the BSL-3 facility. Th... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571394 (4-chloro-N-(4-((4-hydroxypiperidin-1-yl)methyl)phe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description After infection, supernatants were removed, and cells were fixed with 4% formaldehyde for 24 hours prior to being removed from the BSL-3 facility. Th... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571386 (N-(4-((1,4-oxazepan-4-yl)methyl)phenyl)-4-chlorobe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM50421867 (CHEMBL216826) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem | n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571386 (N-(4-((1,4-oxazepan-4-yl)methyl)phenyl)-4-chlorobe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description After infection, supernatants were removed, and cells were fixed with 4% formaldehyde for 24 hours prior to being removed from the BSL-3 facility. Th... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571390 (N-(4-((7-oxa-2-azaspiro[3.5]nonan-2-yl)methyl)phen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description After infection, supernatants were removed, and cells were fixed with 4% formaldehyde for 24 hours prior to being removed from the BSL-3 facility. Th... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571396 (4-chloro-N-(4-((4-methylpiperazin-1-yl)methyl)phen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 700 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description After infection, supernatants were removed, and cells were fixed with 4% formaldehyde for 24 hours prior to being removed from the BSL-3 facility. Th... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571387 (N-(4-((2-oxa-6-azaspiro[3.3]heptan-6-yl)methyl)phe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The SARS-CoV-2 isolate BetaCoV/France/IDF0372/2020 (SARS-CoV-2 Paris) was supplied by the National Reference Centre for Respiratory Viruses hosted by... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571389 (2-chloro-N-(4-(morpholinomethyl)phenyl)pyrimidine-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description After infection, supernatants were removed, and cells were fixed with 4% formaldehyde for 24 hours prior to being removed from the BSL-3 facility. Th... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571387 (N-(4-((2-oxa-6-azaspiro[3.3]heptan-6-yl)methyl)phe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description After infection, supernatants were removed, and cells were fixed with 4% formaldehyde for 24 hours prior to being removed from the BSL-3 facility. Th... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571393 (4-chloro-N-(4-(((3aR,6aS)-tetrahydro-1H-furo[3,4-c...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571390 (N-(4-((7-oxa-2-azaspiro[3.5]nonan-2-yl)methyl)phen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The SARS-CoV-2 isolate BetaCoV/France/IDF0372/2020 (SARS-CoV-2 Paris) was supplied by the National Reference Centre for Respiratory Viruses hosted by... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571394 (4-chloro-N-(4-((4-hydroxypiperidin-1-yl)methyl)phe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571386 (N-(4-((1,4-oxazepan-4-yl)methyl)phenyl)-4-chlorobe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The SARS-CoV-2 isolate BetaCoV/France/IDF0372/2020 (SARS-CoV-2 Paris) was supplied by the National Reference Centre for Respiratory Viruses hosted by... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571394 (4-chloro-N-(4-((4-hydroxypiperidin-1-yl)methyl)phe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The SARS-CoV-2 isolate BetaCoV/France/IDF0372/2020 (SARS-CoV-2 Paris) was supplied by the National Reference Centre for Respiratory Viruses hosted by... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571390 (N-(4-((7-oxa-2-azaspiro[3.5]nonan-2-yl)methyl)phen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571396 (4-chloro-N-(4-((4-methylpiperazin-1-yl)methyl)phen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The SARS-CoV-2 isolate BetaCoV/France/IDF0372/2020 (SARS-CoV-2 Paris) was supplied by the National Reference Centre for Respiratory Viruses hosted by... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571393 (4-chloro-N-(4-(((3aR,6aS)-tetrahydro-1H-furo[3,4-c...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The SARS-CoV-2 isolate BetaCoV/France/IDF0372/2020 (SARS-CoV-2 Paris) was supplied by the National Reference Centre for Respiratory Viruses hosted by... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571391 (N-(4-((1-oxa-7-azaspiro[4.4]nonan-7-yl)methyl)phen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.90E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571392 (N-(4-(((1R,5S)-3-oxa-7-azabicyclo[3.3.1]nonan-7-yl...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571395 (4-chloro-N-(4-((3-hydroxypyrrolidin-1-yl)methyl)ph...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571396 (4-chloro-N-(4-((4-methylpiperazin-1-yl)methyl)phen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM83797 (6-Bromo-4-dimethylaminomethyl-5-hydroxy-1-methyl-2...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase MCE PC cid PC sid PDB UniChem Similars | n/a | n/a | 4.11E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540829 ((3-(4-chlorophenyl) isoxazol-5-yl) methyl-(2alpha,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.12E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM428875 (med.21724, Compound 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | n/a | n/a | 4.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM32188 (CLIOQUINOL | Clioquinol (CQ) | TG2-36-2 | cid_2788) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase DrugBank MCE MMDB PC cid PC sid PDB UniChem Patents | Article PubMed | n/a | n/a | 5.60E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Inhibition of SARS-COV2 ACE2 binding to spike glycoprotein S RBD domain preincubated for 31 mins with RBD followed by protein addition measured after... | Citation and Details Article DOI: 10.1021/acs.jmedchem.1c01547 BindingDB Entry DOI: 10.7270/Q25H7M47 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571391 (N-(4-((1-oxa-7-azaspiro[4.4]nonan-7-yl)methyl)phen...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 6.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description After infection, supernatants were removed, and cells were fixed with 4% formaldehyde for 24 hours prior to being removed from the BSL-3 facility. Th... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571387 (N-(4-((2-oxa-6-azaspiro[3.3]heptan-6-yl)methyl)phe...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM571389 (2-chloro-N-(4-(morpholinomethyl)phenyl)pyrimidine-...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.40E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description Cells were seeded in 24-well plates at a concentration of 7.5×104 cells/well. The following day, serial dilutions were performed in serum-free MEM me... | Citation and Details BindingDB Entry DOI: 10.7270/Q2SN0D6Z | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM7459 (2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | n/a | n/a | 1.06E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540813 (Propargyl- (3beta)-3- hydroxyolean- 12-en-28-oate ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 4.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540821 ((1-(3- methylphenyl)-1H- 1,2,3-triazol- 4-yl)methy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.53E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM7460 (2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chrome...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | n/a | n/a | 8.34E+4 | n/a | n/a | n/a | n/a | n/a | n/a | |
TBA | Citation and Details | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540815 (Propargyl-(2alpha)-2- (propargyloxy)- (3beta)-3-hy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 8.52E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM50590308 (CHEMBL5201689) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | Article PubMed | n/a | n/a | 8.69E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Citation and Details Article DOI: 10.1039/d1md00264c BindingDB Entry DOI: 10.7270/Q208698Z | ||||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540812 (Maslinic acid | US11266632, Compound 2) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 9.99E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540818 (Propargyl- (2alpha,3beta)-2,3- bis(propargyloxy)- ...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.08E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540823 ((1-(4- Chlorophenyl)-1H- 1,2,3-triazol- 4-yl)methy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.16E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540820 ((1-(3- methylphenyl)-1H- 1,2,3-triazol- 5-yl)methy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.32E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540822 ((1-Phenyl-1H- 1,2,3-triazol-4- yl)methyl- (2alpha,...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.35E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540817 (Propargyl-(3alpha)-3- (propargyloxy)- (2beta)-2-hy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.35E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540826 ((1-(4- Methoxyphenyl)- 1H-1,2,3- triazol-4-yl)meth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.37E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540824 ((1-(4- Methoxyphenyl)- 1H-1,2,3- triazol-4-yl)meth...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.59E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM540819 ((1-(3- mcthylphenyl)-1H- 1,2,3-triazol- 5-yl)methy...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 1.74E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The IC50 values for the tested compounds were determined as previously described [2, 3], with minor modifications. Briefly, in 96-well tissue culture... | Citation and Details BindingDB Entry DOI: 10.7270/Q25H7KG9 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Spike glycoprotein (2019-nCoV) | BDBM11318 (1,3,8-trihydroxy-6-methyl-9,10-dihydroanthracene-9...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase CHEMBL DrugBank MCE KEGG MMDB PC cid PC sid PDB UniChem Patents Similars | Article PubMed | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Citation and Details Article DOI: 10.1021/acs.jnatprod.0c00968 BindingDB Entry DOI: 10.7270/Q27P93C8 | ||||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 54 total ) | Next | Last >> |